Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Mayo Clinic Proceedings|November 14, 1997
Overexpression of p34cdc2 protein kinase in epithelial ovarian carcinomaB A Barrette, P J Srivatsa, W A Cliby, et al.
Genes, Chromosomes & Cancer|April 30, 1999
Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancerJ B Villeneuve, M B Silverman, B Alderete, et al.
European Journal of Gynaecological Oncology|March 31, 2010
Referral and ascertainment bias in patients with synchronous and metachronous endometrial malignancyA Mariani, S S Cha, E J Bergstralh, et al.
American Journal of Obstetrics and Gynecology|November 1, 1996
Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survivalG Zanetta, G L Keeney, S S Cha, et al.
Gynecologic Oncology|December 22, 2007
Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional reviewM Thomas, A Mariani, J D Wright, et al.
Gynecologic Oncology|September 23, 1997
Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancerG S Leiserowitz, A H Russell, W K Kinney, et al.
Gynecologic Oncology|November 1, 1992
Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy and survivalL C Hartmann, T J Sebo, N A Kamel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1996
Absence of mutations in DNA mismatch repair genes in sporadic endometrial tumors with microsatellite instabilityP C Lim, D Tester, W Cliby, et al.
Gynecologic Oncology|August 1, 1997
Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinomaP J Srivatsa, W A Cliby, G L Keeney, et al.
Gynecologic Oncology|April 1, 1996
Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trialJ P Curtin, W J Hoskins, E S Venkatraman, et al.
Pageof 12